Non-opioid Analgesic Patch Market
1 Non-opioid Analgesic Patch Market Overview
1.1 Product Overview and Scope of Non-opioid Analgesic Patch
1.2 Non-opioid Analgesic Patch Segment by Type
1.2.1 Global Non-opioid Analgesic Patch Sales Growth Rate Comparison by Type (2023-2030)
1.2.2 Lidocaine Patches
1.2.3 Diclofenac Patches
1.2.4 Methyl Salicylate Patches
1.2.5 Capsaicin Patches
1.2.6 Ketoprofen Patches
1.2.7 Others
1.3 Non-opioid Analgesic Patch Segment by Application
1.3.1 Global Non-opioid Analgesic Patch Sales Comparison by Application: (2023-2030)
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Independent Pharmacies & Drug Stores
1.4 Global Non-opioid Analgesic Patch Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Analgesic Patch Revenue 2017-2030
1.4.2 Global Non-opioid Analgesic Patch Sales 2017-2030
1.4.3 Non-opioid Analgesic Patch Market Size by Region: 2017 Versus 2021 Versus 2030
2 Non-opioid Analgesic Patch Market Competition by Manufacturers
2.1 Global Non-opioid Analgesic Patch Sales Market Share by Manufacturers (2017-2023)
2.2 Global Non-opioid Analgesic Patch Revenue Market Share by Manufacturers (2017-2023)
2.3 Global Non-opioid Analgesic Patch Average Price by Manufacturers (2017-2023)
2.4 Manufacturers Non-opioid Analgesic Patch Manufacturing Sites, Area Served, Product Type
2.5 Non-opioid Analgesic Patch Market Competitive Situation and Trends
2.5.1 Non-opioid Analgesic Patch Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Non-opioid Analgesic Patch Players Market Share by Revenue
2.5.3 Global Non-opioid Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Analgesic Patch Retrospective Market Scenario by Region
3.1 Global Non-opioid Analgesic Patch Retrospective Market Scenario in Sales by Region: 2017-2023
3.2 Global Non-opioid Analgesic Patch Retrospective Market Scenario in Revenue by Region: 2017-2023
3.3 North America Non-opioid Analgesic Patch Market Facts & Figures by Country
3.3.1 North America Non-opioid Analgesic Patch Sales by Country
3.3.2 North America Non-opioid Analgesic Patch Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Non-opioid Analgesic Patch Market Facts & Figures by Country
3.4.1 Europe Non-opioid Analgesic Patch Sales by Country
3.4.2 Europe Non-opioid Analgesic Patch Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Non-opioid Analgesic Patch Market Facts & Figures by Region
3.5.1 Asia Pacific Non-opioid Analgesic Patch Sales by Region
3.5.2 Asia Pacific Non-opioid Analgesic Patch Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Non-opioid Analgesic Patch Market Facts & Figures by Country
3.6.1 Latin America Non-opioid Analgesic Patch Sales by Country
3.6.2 Latin America Non-opioid Analgesic Patch Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Non-opioid Analgesic Patch Market Facts & Figures by Country
3.7.1 Middle East and Africa Non-opioid Analgesic Patch Sales by Country
3.7.2 Middle East and Africa Non-opioid Analgesic Patch Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Non-opioid Analgesic Patch Historic Market Analysis by Type
4.1 Global Non-opioid Analgesic Patch Sales Market Share by Type (2017-2023)
4.2 Global Non-opioid Analgesic Patch Revenue Market Share by Type (2017-2023)
4.3 Global Non-opioid Analgesic Patch Price by Type (2017-2023)
5 Global Non-opioid Analgesic Patch Historic Market Analysis by Application
5.1 Global Non-opioid Analgesic Patch Sales Market Share by Application (2017-2023)
5.2 Global Non-opioid Analgesic Patch Revenue Market Share by Application (2017-2023)
5.3 Global Non-opioid Analgesic Patch Price by Application (2017-2023)
6 Key Companies Profiled
6.1 GlaxoSmithKline Plc
6.1.1 GlaxoSmithKline Plc Corporation Information
6.1.2 GlaxoSmithKline Plc Description and Business Overview
6.1.3 GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.1.4 GlaxoSmithKline Plc Non-opioid Analgesic Patch Product Portfolio
6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
6.2 Pfizer, Inc.
6.2.1 Pfizer, Inc. Corporation Information
6.2.2 Pfizer, Inc. Description and Business Overview
6.2.3 Pfizer, Inc. Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.2.4 Pfizer, Inc. Non-opioid Analgesic Patch Product Portfolio
6.2.5 Pfizer, Inc. Recent Developments/Updates
6.3 Teikoku Seiyaku Co., Ltd.
6.3.1 Teikoku Seiyaku Co., Ltd. Corporation Information
6.3.2 Teikoku Seiyaku Co., Ltd. Description and Business Overview
6.3.3 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.3.4 Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product Portfolio
6.3.5 Teikoku Seiyaku Co., Ltd. Recent Developments/Updates
6.4 Mylan N.V.
6.4.1 Mylan N.V. Corporation Information
6.4.2 Mylan N.V. Description and Business Overview
6.4.3 Mylan N.V. Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Mylan N.V. Non-opioid Analgesic Patch Product Portfolio
6.4.5 Mylan N.V. Recent Developments/Updates
6.5 Hisamitsu Pharmaceutical Co.,Inc
6.5.1 Hisamitsu Pharmaceutical Co.,Inc Corporation Information
6.5.2 Hisamitsu Pharmaceutical Co.,Inc Description and Business Overview
6.5.3 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.5.4 Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product Portfolio
6.5.5 Hisamitsu Pharmaceutical Co.,Inc Recent Developments/Updates
6.6 Acorda Therapeutics, Inc
6.6.1 Acorda Therapeutics, Inc Corporation Information
6.6.2 Acorda Therapeutics, Inc Description and Business Overview
6.6.3 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.6.4 Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product Portfolio
6.6.5 Acorda Therapeutics, Inc Recent Developments/Updates
6.7 Endo International plc
6.6.1 Endo International plc Corporation Information
6.6.2 Endo International plc Description and Business Overview
6.6.3 Endo International plc Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.4.4 Endo International plc Non-opioid Analgesic Patch Product Portfolio
6.7.5 Endo International plc Recent Developments/Updates
6.8 Allergan
6.8.1 Allergan Corporation Information
6.8.2 Allergan Description and Business Overview
6.8.3 Allergan Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.8.4 Allergan Non-opioid Analgesic Patch Product Portfolio
6.8.5 Allergan Recent Developments/Updates
6.9 Teh Seng Pharmaceutical Mfg
6.9.1 Teh Seng Pharmaceutical Mfg Corporation Information
6.9.2 Teh Seng Pharmaceutical Mfg Description and Business Overview
6.9.3 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.9.4 Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product Portfolio
6.9.5 Teh Seng Pharmaceutical Mfg Recent Developments/Updates
6.10 IBSA Institut Biochimque SA
6.10.1 IBSA Institut Biochimque SA Corporation Information
6.10.2 IBSA Institut Biochimque SA Description and Business Overview
6.10.3 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales, Revenue and Gross Margin (2017-2023)
6.10.4 IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product Portfolio
6.10.5 IBSA Institut Biochimque SA Recent Developments/Updates
7 Non-opioid Analgesic Patch Manufacturing Cost Analysis
7.1 Non-opioid Analgesic Patch Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Non-opioid Analgesic Patch
7.4 Non-opioid Analgesic Patch Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Non-opioid Analgesic Patch Distributors List
8.3 Non-opioid Analgesic Patch Customers
9 Non-opioid Analgesic Patch Market Dynamics
9.1 Non-opioid Analgesic Patch Industry Trends
9.2 Non-opioid Analgesic Patch Market Drivers
9.3 Non-opioid Analgesic Patch Market Challenges
9.4 Non-opioid Analgesic Patch Market Restraints
10 Global Market Forecast
10.1 Non-opioid Analgesic Patch Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Non-opioid Analgesic Patch by Type (2023-2030)
10.1.2 Global Forecasted Revenue of Non-opioid Analgesic Patch by Type (2023-2030)
10.2 Non-opioid Analgesic Patch Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Non-opioid Analgesic Patch by Application (2023-2030)
10.2.2 Global Forecasted Revenue of Non-opioid Analgesic Patch by Application (2023-2030)
10.3 Non-opioid Analgesic Patch Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Non-opioid Analgesic Patch by Region (2023-2030)
10.3.2 Global Forecasted Revenue of Non-opioid Analgesic Patch by Region (2023-2030)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Non-opioid Analgesic Patch Sales Growth Rate Comparison by Type (2023-2030) & (K Units) & (US$ Million)
Table 2. Global Non-opioid Analgesic Patch Sales Growth Rate Comparison by Application (2023-2030) & (K Units) & (US$ Million)
Table 3. Global Non-opioid Analgesic Patch Market Size by Region (US$ Million) (2017 VS 2021 VS 2030)
Table 4. Global Non-opioid Analgesic Patch Market Competitive Situation by Manufacturers in 2021
Table 5. Global Non-opioid Analgesic Patch Sales (K Units) of Key Manufacturers (2017-2023)
Table 6. Global Non-opioid Analgesic Patch Sales Market Share by Manufacturers (2017-2023)
Table 7. Global Non-opioid Analgesic Patch Revenue (US$ Million) by Manufacturers (2017-2023)
Table 8. Global Non-opioid Analgesic Patch Revenue Share by Manufacturers (2017-2023)
Table 9. Global Market Non-opioid Analgesic Patch Average Price (USD/Unit) of Key Manufacturers (2017-2023)
Table 10. Manufacturers Non-opioid Analgesic Patch Manufacturing Sites and Area Served
Table 11. Manufacturers Non-opioid Analgesic Patch Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Non-opioid Analgesic Patch by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Non-opioid Analgesic Patch as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Non-opioid Analgesic Patch Sales by Region (2017-2023) & (K Units)
Table 16. Global Non-opioid Analgesic Patch Sales Market Share by Region (2017-2023)
Table 17. Global Non-opioid Analgesic Patch Revenue by Region (2017-2023) & (US$ Million)
Table 18. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2017-2023)
Table 19. North America Non-opioid Analgesic Patch Sales by Country (2017-2023) & (K Units)
Table 20. North America Non-opioid Analgesic Patch Sales Market Share by Country (2017-2023)
Table 21. North America Non-opioid Analgesic Patch Revenue by Country (2017-2023) & (US$ Million)
Table 22. North America Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2023)
Table 23. Europe Non-opioid Analgesic Patch Sales by Country (2017-2023) & (K Units)
Table 24. Europe Non-opioid Analgesic Patch Sales Market Share by Country (2017-2023)
Table 25. Europe Non-opioid Analgesic Patch Revenue by Country (2017-2023) & (US$ Million)
Table 26. Europe Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2023)
Table 27. Asia Pacific Non-opioid Analgesic Patch Sales by Region (2017-2023) & (K Units)
Table 28. Asia Pacific Non-opioid Analgesic Patch Sales Market Share by Region (2017-2023)
Table 29. Asia Pacific Non-opioid Analgesic Patch Revenue by Region (2017-2023) & (US$ Million)
Table 30. Asia Pacific Non-opioid Analgesic Patch Revenue Market Share by Region (2017-2023)
Table 31. Latin America Non-opioid Analgesic Patch Sales by Country (2017-2023) & (K Units)
Table 32. Latin America Non-opioid Analgesic Patch Sales Market Share by Country (2017-2023)
Table 33. Latin America Non-opioid Analgesic Patch Revenue by Country (2017-2023) & (US$ Million)
Table 34. Latin America Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2023)
Table 35. Middle East and Africa Non-opioid Analgesic Patch Sales by Country (2017-2023) & (K Units)
Table 36. Middle East and Africa Non-opioid Analgesic Patch Sales Market Share by Country (2017-2023)
Table 37. Middle East and Africa Non-opioid Analgesic Patch Revenue by Country (2017-2023) & (US$ Million)
Table 38. Middle East and Africa Non-opioid Analgesic Patch Revenue Market Share by Country (2017-2023)
Table 39. Global Non-opioid Analgesic Patch Sales by Type (2017-2023) & (K Units)
Table 40. Global Non-opioid Analgesic Patch Sales Market Share by Type (2017-2023)
Table 41. Global Non-opioid Analgesic Patch Revenue by Type (2017-2023) & (US$ Million)
Table 42. Global Non-opioid Analgesic Patch Revenue Share by Type (2017-2023)
Table 43. Global Non-opioid Analgesic Patch Price by Type (2017-2023) & (USD/Unit)
Table 44. Global Non-opioid Analgesic Patch Sales (K Units) by Application (2017-2023)
Table 45. Global Non-opioid Analgesic Patch Sales Market Share by Application (2017-2023)
Table 46. Global Non-opioid Analgesic Patch Revenue by Application (2017-2023) & (US$ Million)
Table 47. Global Non-opioid Analgesic Patch Revenue Share by Application (2017-2023)
Table 48. Global Non-opioid Analgesic Patch Price by Application (2017-2023) & (USD/Unit)
Table 49. GlaxoSmithKline Plc Corporation Information
Table 50. GlaxoSmithKline Plc Description and Business Overview
Table 51. GlaxoSmithKline Plc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 52. GlaxoSmithKline Plc Non-opioid Analgesic Patch Product
Table 53. GlaxoSmithKline Plc Recent Developments/Updates
Table 54. Pfizer, Inc. Corporation Information
Table 55. Pfizer, Inc. Description and Business Overview
Table 56. Pfizer, Inc. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 57. Pfizer, Inc. Non-opioid Analgesic Patch Product
Table 58. Pfizer, Inc. Recent Developments/Updates
Table 59. Teikoku Seiyaku Co., Ltd. Corporation Information
Table 60. Teikoku Seiyaku Co., Ltd. Description and Business Overview
Table 61. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 62. Teikoku Seiyaku Co., Ltd. Non-opioid Analgesic Patch Product
Table 63. Teikoku Seiyaku Co., Ltd. Recent Developments/Updates
Table 64. Mylan N.V. Corporation Information
Table 65. Mylan N.V. Description and Business Overview
Table 66. Mylan N.V. Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 67. Mylan N.V. Non-opioid Analgesic Patch Product
Table 68. Mylan N.V. Recent Developments/Updates
Table 69. Hisamitsu Pharmaceutical Co.,Inc Corporation Information
Table 70. Hisamitsu Pharmaceutical Co.,Inc Description and Business Overview
Table 71. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 72. Hisamitsu Pharmaceutical Co.,Inc Non-opioid Analgesic Patch Product
Table 73. Hisamitsu Pharmaceutical Co.,Inc Recent Developments/Updates
Table 74. Acorda Therapeutics, Inc Corporation Information
Table 75. Acorda Therapeutics, Inc Description and Business Overview
Table 76. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 77. Acorda Therapeutics, Inc Non-opioid Analgesic Patch Product
Table 78. Acorda Therapeutics, Inc Recent Developments/Updates
Table 79. Endo International plc Corporation Information
Table 80. Endo International plc Description and Business Overview
Table 81. Endo International plc Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 82. Endo International plc Non-opioid Analgesic Patch Product
Table 83. Endo International plc Recent Developments/Updates
Table 84. Allergan Corporation Information
Table 85. Allergan Description and Business Overview
Table 86. Allergan Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 87. Allergan Non-opioid Analgesic Patch Product
Table 88. Allergan Recent Developments/Updates
Table 89. Teh Seng Pharmaceutical Mfg Corporation Information
Table 90. Teh Seng Pharmaceutical Mfg Description and Business Overview
Table 91. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 92. Teh Seng Pharmaceutical Mfg Non-opioid Analgesic Patch Product
Table 93. Teh Seng Pharmaceutical Mfg Recent Developments/Updates
Table 94. IBSA Institut Biochimque SA Corporation Information
Table 95. IBSA Institut Biochimque SA Description and Business Overview
Table 96. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2023)
Table 97. IBSA Institut Biochimque SA Non-opioid Analgesic Patch Product
Table 98. IBSA Institut Biochimque SA Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Non-opioid Analgesic Patch Distributors List
Table 102. Non-opioid Analgesic Patch Customers List
Table 103. Non-opioid Analgesic Patch Market Trends
Table 104. Non-opioid Analgesic Patch Market Drivers
Table 105. Non-opioid Analgesic Patch Market Challenges
Table 106. Non-opioid Analgesic Patch Market Restraints
Table 107. Global Non-opioid Analgesic Patch Sales Forecast by Type (2023-2030) & (K Units)
Table 108. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Type (2023-2030)
Table 109. Global Non-opioid Analgesic Patch Revenue Forecast by Type (2023-2030) & (US$ Million)
Table 110. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Type (2023-2030)
Table 111. Global Non-opioid Analgesic Patch Sales Forecast by Application (2023-2030) & (K Units)
Table 112. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Application (2023-2030)
Table 113. Global Non-opioid Analgesic Patch Revenue Forecast by Application (2023-2030) & (US$ Million)
Table 114. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Application (2023-2030)
Table 115. Global Non-opioid Analgesic Patch Sales Forecast by Region (2023-2030) & (K Units)
Table 116. Global Non-opioid Analgesic Patch Sales Market Share Forecast by Region (2023-2030)
Table 117. Global Non-opioid Analgesic Patch Revenue Forecast by Region (2023-2030) & (US$ Million)
Table 118. Global Non-opioid Analgesic Patch Revenue Market Share Forecast by Region (2023-2030)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Analgesic Patch
Figure 2. Global Non-opioid Analgesic Patch Market Share by Type in 2021 & 2030
Figure 3. Lidocaine Patches Product Picture
Figure 4. Diclofenac Patches Product Picture
Figure 5. Methyl Salicylate Patches Product Picture
Figure 6. Capsaicin Patches Product Picture
Figure 7. Ketoprofen Patches Product Picture
Figure 8. Others Product Picture
Figure 9. Global Non-opioid Analgesic Patch Market Share by Application in 2021 & 2030
Figure 10. Hospital Pharmacies
Figure 11. Online Pharmacies
Figure 12. Independent Pharmacies & Drug Stores
Figure 13. Global Non-opioid Analgesic Patch Revenue, (US$ Million), 2017 VS 2021 VS 2030
Figure 14. Global Non-opioid Analgesic Patch Market Size (2017-2030) & (US$ Million)
Figure 15. Global Non-opioid Analgesic Patch Sales (2017-2030) & (K Units)
Figure 16. Non-opioid Analgesic Patch Sales Share by Manufacturers in 2021
Figure 17. Global Non-opioid Analgesic Patch Revenue Share by Manufacturers in 2021
Figure 18. The Global 5 and 10 Largest Non-opioid Analgesic Patch Players: Market Share by Revenue in 2021
Figure 19. Non-opioid Analgesic Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 20. Global Non-opioid Analgesic Patch Sales Market Share by Region (2017-2023)
Figure 21. Global Non-opioid Analgesic Patch Sales Market Share by Region in 2021
Figure 22. Global Non-opioid Analgesic Patch Revenue Market Share by Region (2017-2023)
Figure 23. Global Non-opioid Analgesic Patch Revenue Market Share by Region in 2021
Figure 24. U.S. Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 25. Canada Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 26. Germany Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 27. France Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 28. U.K. Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 29. Italy Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 30. Russia Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 31. China Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 32. Japan Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 33. South Korea Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 34. India Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 35. Australia Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 36. Taiwan Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 37. Indonesia Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 38. Thailand Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 39. Malaysia Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 40. Philippines Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 41. Vietnam Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 42. Mexico Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 43. Brazil Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 44. Argentina Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 45. Turkey Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 46. Saudi Arabia Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 47. UAE Non-opioid Analgesic Patch Revenue Growth Rate (2017-2023) & (US$ Million)
Figure 48. Sales Market Share of Non-opioid Analgesic Patch by Type (2017-2023)
Figure 49. Manufacturing Cost Structure of Non-opioid Analgesic Patch
Figure 50. Manufacturing Process Analysis of Non-opioid Analgesic Patch
Figure 51. Non-opioid Analgesic Patch Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
